ACM
CABA icon

ADAR1 Capital Management’s Cabaletta Bio CABA Stock Holding History

ADAR1 Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156K Buy
+50,000
New +$164K 0.01% 253
2024
Q2 		– Sell
-8,900
Closed -$152K – 280
2024
Q1 		$152K Buy
+8,900
New +$191K 0.03% 131

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

ADAR1 Capital Management's CABA Position: Q2 2026 in Review

ADAR1 Capital Management opened a new position in Cabaletta Bio (CABA) in Q2 2026: 50,000 shares worth $156K. The stake represents 0.01% of the portfolio and ranks #253 among its holdings. This is a return to the name: ADAR1 Capital Management previously reported a position in CABA as recently as Q1 2024.

ADAR1 Capital Management first reported a position in CABA in Q1 2024 and has held it in 2 quarters since. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • ADAR1 Capital Management held 50,000 shares of Cabaletta Bio worth $156K as of Q2 2026.
  • Cabaletta Bio was a new ADAR1 Capital Management position in Q2 2026.
  • Cabaletta Bio made up 0.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #253 holding.
  • ADAR1 Capital Management first reported a position in Cabaletta Bio in Q1 2024 and has held it in 2 quarters since.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.